Glioblastoma (GBM) is a highly aggressive primary brain tumor characterized by profound immunosuppression that facilitates tumor progression and promotes therapeutic resistance. Fibroblast activation protein (FAP), a recognized theranostic target in multiple cancers, is upregulated in GBM and predominantly expressed by...
Magdalena Houdova Megova, C. Shard, B. Výmolová et al.· Experimental and Molecular M...· 0 citations
Effective glioblastoma care requires integrating multiparametric longitudinal MRI with histopathology, molecular profiling, and clinical records documenting surgery, radiotherapy, chemotherapy, and supportive treatments. In routine practice, however, these data streams are often evaluated separately rather than jointly...
Amin Zadeh-Shirazi, Bryan W. Day, Hui K. Gan et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.